699 related articles for article (PubMed ID: 17000960)
1. Is late-onset multiple sclerosis associated with a worse outcome?
Tremlett H; Devonshire V
Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
[TBL] [Abstract][Full Text] [Related]
2. Natural history of secondary-progressive multiple sclerosis.
Tremlett H; Yinshan Zhao ; Devonshire V
Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
[TBL] [Abstract][Full Text] [Related]
3. Disability progression in multiple sclerosis is slower than previously reported.
Tremlett H; Paty D; Devonshire V
Neurology; 2006 Jan; 66(2):172-7. PubMed ID: 16434648
[TBL] [Abstract][Full Text] [Related]
4. Effect of gender on late-onset multiple sclerosis.
Bove RM; Healy B; Augustine A; Musallam A; Gholipour T; Chitnis T
Mult Scler; 2012 Oct; 18(10):1472-9. PubMed ID: 22383227
[TBL] [Abstract][Full Text] [Related]
5. The natural history of primary progressive multiple sclerosis.
Koch M; Kingwell E; Rieckmann P; Tremlett H
Neurology; 2009 Dec; 73(23):1996-2002. PubMed ID: 19996074
[TBL] [Abstract][Full Text] [Related]
6. The natural history of primary progressive MS in British Columbia, Canada.
Tremlett H; Paty D; Devonshire V
Neurology; 2005 Dec; 65(12):1919-23. PubMed ID: 16380613
[TBL] [Abstract][Full Text] [Related]
7. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
Guillemin F; Baumann C; Epstein J; Kerschen P; Garot T; Mathey G; Debouverie M;
Neuroepidemiology; 2017; 48(3-4):179-187. PubMed ID: 28793296
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
El-Salem K; Khader Y
Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
[TBL] [Abstract][Full Text] [Related]
9. Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia.
Qiu W; Wu JS; Castley A; James I; Joseph J; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
J Clin Neurosci; 2010 Aug; 17(8):1009-13. PubMed ID: 20580995
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts.
Kingwell E; Leung AL; Roger E; Duquette P; Rieckmann P; Tremlett H;
J Neurol Sci; 2010 May; 292(1-2):57-62. PubMed ID: 20202651
[TBL] [Abstract][Full Text] [Related]
11. [Late onset multiple sclerosis].
Delalande S; De Seze J; Ferriby D; Stojkovic T; Vermersch P
Rev Neurol (Paris); 2002 Nov; 158(11):1082-7. PubMed ID: 12451340
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.
Mirmosayyeb O; Brand S; Barzegar M; Afshari-Safavi A; Nehzat N; Shaygannejad V; Sadeghi Bahmani D
J Clin Med; 2020 May; 9(5):. PubMed ID: 32370288
[TBL] [Abstract][Full Text] [Related]
13. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.
Mouresan EF; Mentesidou E; Berglund A; McKay KA; Hillert J; Iacobaeus E
Neurology; 2024 Mar; 102(6):e208051. PubMed ID: 38394472
[TBL] [Abstract][Full Text] [Related]
15. Late-onset multiple sclerosis in Isfahan, Iran.
Etemadifar M; Abtahi SH; Minagar A; Akbari M; Masaeli A; Tabrizi N
Arch Iran Med; 2012 Oct; 15(10):596-8. PubMed ID: 23020533
[TBL] [Abstract][Full Text] [Related]
16. Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
Alroughani R; Akhtar S; Ahmed S; Behbehani R; Al-Hashel J
PLoS One; 2016; 11(11):e0165846. PubMed ID: 27802328
[TBL] [Abstract][Full Text] [Related]
17. The clinical course of multiple sclerosis patients in Hong Kong.
Lau KK; Wong WW; Sheng B; Yu IT; Fung BH; Li HL; Ma KF; Wong LK; Li PC
J Neurol Sci; 2008 May; 268(1-2):78-82. PubMed ID: 18068191
[TBL] [Abstract][Full Text] [Related]
18. Natural history of multiple sclerosis: a unifying concept.
Confavreux C; Vukusic S
Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.
Shirani A; Zhao Y; Petkau J; Gustafson P; Karim ME; Evans C; Kingwell E; van der Kop ML; Oger J; Tremlett H
Biomed Res Int; 2015; 2015():451912. PubMed ID: 25922836
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.
Ghezzi A; Bergamaschi R; Martinelli V; Trojano M; Tola MR; Merelli E; Mancardi L; Gallo P; Filippi M; Zaffaroni M; Comi G;
J Neurol; 2004 Jan; 251(1):47-52. PubMed ID: 14999489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
